Background
Human pluripotent stem cell derived cardiomyocytes (hPCMs) may regenerate the myocardium to restore the cardiac function. Manganese-enhanced MRI (MEMRI) enters the cardiomyocytes via calcium channel to generate viability signal directly. Persistent engraftment of the hPCMs associated with increased myocardial viability and LVEF suggests regeneration. This study tests the hypothesis that hPCMs regenerate the injured murine myocardium.
Methods 0.5 million human pluripotent stem cells and their cardiomyocyte derivatives were delivered into the injured SCID murine myocardium: iPSCs (n=3), hESCs (n=3), hCMs (n=3), iCMs (n=12), and PBS (n=4). MEMRI and cardiac MRI evaluated viability and function (3T HDx, GEHC, WI), using SeeMore IV (Eagle Vision, PA) on days 14 and 28 days post-MI. Bioluminescence imaging (BLI, Xenogen IVIS 200, MA) was performed to assess engraftment of the reporter gene transcued-iCMs (RG-iCMs).
Results
The mean LVEF on days 14 and 28 post-MI demonstrated significant improvement in the hPCM groups vs. PBS control and undifferentiated cell groups. On days 14 and 28, the following LVEF measurements were observed: 1) Day 
Conclusions
Multimodality MRI-BLI platform allows reliable in vivo detection of myocardial regeneration through evaluation of stem cell engraftment, myocardial viability, and cardiac function. The findings suggest that the regenerative effects of hPCMs sustain the restoration of the injured myocardium.
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